Angiogenesis in melanoma: an update with a focus on current targeted therapies

被引:57
|
作者
Jour, George [1 ]
Ivan, Doina [1 ]
Aung, Phyu P. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 0085,1515 Holcombe Blvd, Houston, TX 77030 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; PRIMARY CUTANEOUS MELANOMA; MATRIX-METALLOPROTEINASE INHIBITOR; METASTATIC MALIGNANT-MELANOMA; VON-WILLEBRAND-FACTOR; PRIMARY TUMOR-GROWTH; STAGE IV MELANOMA; PHASE-II; IN-VIVO; VASCULOGENIC MIMICRY;
D O I
10.1136/jclinpath-2015-203482
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Angiogenesis plays a crucial role in melanoma metastasis and progression. In recent years, numerous studies have investigated the prognostic and clinical significance of this phenomenon, and the development of molecular techniques has enabled us to achieve a better understanding of angiogenesis in melanoma. Herein, we review the current state of knowledge regarding angiogenesis in melanoma, including the pathophysiological, histological and immunohistochemical aspects of this phenomenon. We also review the molecular pathways involved in angiogenesis and the interplay between different components that might be manipulated in the future development of efficient targeted therapies. Recently developed targeted antiangiogenic therapies in clinical trials and included in the treatment of advanced-stage melanoma are also reviewed.
引用
收藏
页码:472 / 483
页数:12
相关论文
共 50 条
  • [31] Targeted Therapies for Melanoma Brain Metastases
    Berghoff, Anna S.
    Preusser, Matthias
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (04)
  • [32] Targeted therapies in gynecologic cancers and melanoma
    Ortega, Eugenia
    Marti, Rosa M.
    Yeramian, Andree
    Sorolla, Anabel
    Dolcet, Xavier
    Llobet, David
    Abal, Leandro
    Santacana, Maria
    Pallares, Judit
    Llombart-Cussac, Antonio
    Matias-Guiu, Xavier
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2008, 25 (04) : 262 - 273
  • [33] Targeted Therapies for Melanoma Brain Metastases
    Anna S. Berghoff
    Matthias Preusser
    Current Treatment Options in Neurology, 2017, 19
  • [34] Novel Targeted Therapies for Metastatic Melanoma
    Iams, Wade T.
    Sosman, Jeffrey A.
    Chandra, Sunandana
    CANCER JOURNAL, 2017, 23 (01): : 54 - 58
  • [35] BRAF Signaling and Targeted Therapies in Melanoma
    Dhomen, Nathalie
    Marais, Richard
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (03) : 529 - +
  • [36] Novel targeted combinational therapies for melanoma
    Suriano, Robert
    Tuli, Neha Y.
    Geliebter, Jan
    Tiwari, Raj K.
    Wallack, Marc
    CANCER RESEARCH, 2015, 75
  • [37] Molecular targeted therapies in metastatic melanoma
    Chakraborty, Rima
    Wieland, Carilyn N.
    Comfere, Nneka I.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2013, 6 : 49 - 56
  • [38] Nanosystems for Improved Targeted Therapies in Melanoma
    Beiu, Cristina
    Giurcaneanu, Calin
    Grumezescu, Alexandru Mihai
    Holban, Alina Maria
    Popa, Liliana Gabriela
    Mihai, Mara Madalina
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [39] Molecular alterations in melanoma and targeted therapies
    Mourah, Samia
    Lebbe, Celeste
    BULLETIN DU CANCER, 2014, 101 : S5 - S11
  • [40] Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies
    Kwong, Andrew
    Sanlorenzo, Martina
    Rappersberger, Klemens
    Vujic, Igor
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2019, 169 (13-14) : 314 - 322